MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.
The Hazer Group [ASX:HZR] share price sinks as the hydrogen tech developer completes a $7 million placement. Hazer will also invite eligible shareholders to participate in a share purchase plan to raise up to $7 million.
The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.
The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.
Small-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently trading 7.92% higher at time of writing...
The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...
The Alcidion Group [ASX:ALC] reported record revenue for FY21 of $25.9 million. The record revenue was not enough to increase the ALC shares price, with the Alcidion stock currently down 1.5%.
Redbubble Ltd has had a wild ride over the past year, with a 1,300% rally from 50 cents to $7.22 in 10 months due to a leap in sales during the COVID shutdowns.
Local pot stock Incannex Healthcare [ASX:IHL] is in traders’ sights today. The stock shares is currently up 4.36% and climbing.
Aussie pot stock Creso Pharma [ASX:CPH] share price is on the up today. The share price is currently trading 8% higher at time of writing.